Researchers have developed a unique new method to treat a specific group of patients who are at greater risk of rejecting a donor lung, allowing them to live longer after transplant without rejection. This new approach differs from other therapies which treat patients who are highly sensitized or reactive to foreign donor lung tissue with commonly available and well-tolerated drugs in transplant programs around the world, and is begun only when the patient is in the operating ...
via Medindia Health News
More READ 
Lake forest health and fitness http://ift.tt/1wVYlZt
No comments:
Post a Comment